Considerations for the Utility of Real-World Evidence Beyond Trial Data in Advanced NSCLC: the Case of Frontline Tyrosine Kinase Inhibitors
CANCER MANAGEMENT AND RESEARCH（2022）
关键词
non-small cell lung cancer,short-and long-term outcomes,time to treatment discontinuation,reimbursement
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要